Smoking Cessation

Selected news for the healthcare topic - Smoking Cessation, collected since 10/2017. There are 7.8K items in the archive. This healthcare topic shares news with COVID-19, Public Health, Mental Health, Pfizer, Food and Drug Administration and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/1/2022 Achieve Life Sciences Awarded Grant from National Globe Newswire SEATTLE and VANCOUVER, British Columbia, Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, it has been awarded $2.5 million in grant funding from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) to evaluate the use of cytisinicline as a treatment for cessation of nicotine e ...
5/31/2022 Older Adults Engaged in Digital Health Programs Globe Newswire ... that increased engagement is related to increased weight loss for older adults. For the study, qualified users were enrolled in one of Lark’s AI-powered prevention programs: Lark Prevention and Wellness, which includes smoking cessation , stress and anxiety management, and weight loss, and Lark’s Diabetes Prevention Program, which is Fully Recognized by the Centers for Disease Control and Prevention (CDC). The research was published in the peer-reviewed ...
5/29/2022 Smoking Cessation Aids Market: An Emerging Hint of Opportunity | Reckitt Benckiser, Pfizer, GlaxoSmithKline, Roche, Novartis ccguardian.com Global Smoking Cessation Aids Market Outlook, Analysis, Research, Forecast to 2024The Smoking Cessation Aids market report provides a systematic picture of the sector by way of study, synthesis, and summary of info originated from different sources. The experts have provided the various sides of the sector with a particular goal on identifying the major manipulators of the sector. The Smoking Cessation Aids market report correspondingly comprises a detailed market ...
5/29/2022 Medications for Smoking Cessation Competitive Dynamics & Global Outlook 2028 aeresearch.net Another report distributed on Medications for Smoking Cessation Market offers a broad investigation of key development procedures, drivers, openings, key fragments, Porter’s Five Forces examination, and cutthroat scene. This investigation is a useful wellspring of data for market players, financial backers, VPs, partners, and new participants to acquire an exhaustive comprehension of the business and decide steps to be taken to acquire an upper hand.The Medications for Smoking ...
5/26/2022 How to Pick a Smoking Cessations App psychologytoday.com How to Pick a Smoking Cessations AppThey all claim to help, but which ones really can?Posted May 25, 2022 Reviewed by Tyler WoodsKey points- With hundreds of smoking cessations apps, you can be demanding on quality.- The most popular app may not the the most effective (or even safest).- Focus on an app that offers engagement features that match the unique needs of ...
5/26/2022 Achieve Life Sciences Announces Participation at LD Micro Globe Newswire SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the LD Micro Invitational Conference. The Conference is taking place in-person at the Four Seasons in Westlake Village, CA from June 7 - 9, 2022. Details to ...
5/25/2022 NFL BIOSCIENCES, which is committed to the fight against Globe Newswire NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31NFL BIOSCIENCES, a biopharmaceutical company developing botanical drugs for the treatment of addictions, including NFL-101, a smoking cessation aid drug candidate currently in a Phase II/III clinical trial in France, fully endorses the message and call to action for World No Tobacco Day on May 31, 2022, led by ...
5/21/2022 More cancer patients report quitting smoking with EHR tool: Study Becker's Hospital Review A smoking cessation tool built into an EHR was associated with a decrease in self-reported smoking rates among cancer patients, a recent study in the Journal of the National Comprehensive Cancer Network found.EHR vendor Epic's Elevate platform features a smoking module that notifies oncology clinicians to ask patients their smoking status and, if necessary, offer cessation tips or medications and counseling.According to the study of 3,238 medical ...
5/20/2022 CarolinaEast Medical Center Among Nation's Top Performing Hospitals for Treatment of Heart Attack Patients PR Newswire ... blood clot in a coronary artery partially or completely blocks blood flow to the heart muscle. Treatment guidelines include administering aspirin upon arrival and discharge, timely restoration of blood flow to the blocked artery, smoking cessation counseling and cardiac rehabilitation, among others."It is an honor to award CarolinaEast with the Platinum Performance Award for their valuable national leadership and dedication to meeting comprehensive performance measures in patient care," said ...
5/20/2022 CarolinaEast Medical Center Among Nation's Top Performing Hospitals for Treatment of Heart Attack Patients PR Newswire ... blood clot in a coronary artery partially or completely blocks blood flow to the heart muscle. Treatment guidelines include administering aspirin upon arrival and discharge, timely restoration of blood flow to the blocked artery, smoking cessation counseling and cardiac rehabilitation, among others."It is an honor to award CarolinaEast with the Platinum Performance Award for their valuable national leadership and dedication to meeting comprehensive performance measures in patient care," said ...
5/18/2022 THE FIRST-EVER MEDICAL PSYCHEDELICS SERIES AT DAVOS 2022 hosted by Energia Holdings Incorporated PR Newswire ... reviewed journal Nature, shows that 67% of patients no longer qualified for a PTSD diagnosis a year after treatment with MDMA (or "ecstasy"). Promising results have also been published for treatment of depression and smoking cessation with psilocybin (the psychoactive compound in "magic mushrooms")."Clinical research findings published in recent years suggest that psychoactive compounds could be very effective for treating mental health ailments, though we still have a lot ...
5/17/2022 Mydecine Announces Financial and Globe Newswire ... meeting with the FDA and a conditional Institutional Review Board ("IRB") approval, we are excited, and working towards submitting our full IND and breakthrough therapy applications for our previously announced Phase 2b MYCO-001 Smoking Cessation Study in the near term. Lastly, Mydecine’s science team has been making headway on our second-generation New Chemical Entities ("NCEs") which we hope will lead to increased accessibility by better meeting the ...
5/17/2022 Mydecine Announces First Quarter 2022 Financial Results and Highlights Yahoo News ... meeting with the FDA and a conditional Institutional Review Board ("IRB") approval, we are excited, and working towards submitting our full IND and breakthrough therapy applications for our previously announced Phase 2b MYCO-001 Smoking Cessation Study in the near term. Lastly, Mydecine’s science team has been making headway on our second-generation New Chemical Entities ("NCEs") which we hope will lead to increased accessibility by better meeting the ...
5/17/2022 7 Secrets of Smoking Cessation Can Jump-start the Process pharmacytimes.com Discussing smoking cessation with patients can be difficult.Often patients respond with statements such as “It’s the only pleasure I have” or “I only smoke a few cigarettes a day.” Having a toolkit of talking points can engage patients in cessation efforts or at least start the thought process.Here are 7 facts that may help convince your patients to give up smoking.1. The earlier patients ...
5/16/2022 Unclear role for e-cigarettes during pregnancy Nature Electronic cigarettes might be superior to nicotine replacement therapy as a quitting aid for pregnant women — but enthusiasm is hampered by low rates of smoking cessation and unknown long-term harm.This is a preview of subscription contentAccess optionsSubscribe to JournalGet full journal access for 1 year55,14 €only 4,60 € per issueAll prices are NET prices.VAT will be added later in the ...
5/16/2022 Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial Nature ... 27](/articles/s41591-022-01808-0 ref-CR27) , 28 , and the first few trials comparing the two treatments in non-pregnant participants suggest that e-cigarette are more effective than NRT for aiding smoking cessation 29 , 30 . The use of e-cigarettes as a quitting aid has also increased in pregnant women who smoke 31 , 32 , [33 ...
5/14/2022 Cessation Program in Cancer Clinics May Reach More Tobacco Smokers Physicians Weekly FRIDAY, May 13, 2022 (HealthDay News) — A low-burden point-of-care intervention, featuring an electronic health record-enabled smoking module and decision support tools (ELEVATE) is associated with increased reach and effectiveness of smoking cessation treatment, according to a study published in the May issue of the Journal of the National Comprehensive Cancer Network.Alex T. Ramsey, Ph.D., from the Washington University School of Medicine in St. Louis ...
5/13/2022 Achieve Life Sciences Announces Participation at Best Ideas Globe Newswire SEATTLE and VANCOUVER, British Columbia, Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating at the Spring Into Action Best Ideas Virtual Investor Conference. The conference is taking place virtually from May 16 - 20, 2022. Details for access to the presentation are as follows:Spring Into Action ...
5/12/2022 Achieve Reports Financial Results for First Quarter 2022 Globe Newswire SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced first quarter 2022 financial results and provided an update on the cytisinicline clinical development program.Recent Events & HighlightsReported clinically robust and statistically significant Phase 3 topline results from the ORCA-2 ...
5/11/2022 New Research in JNCCN Encourages Harnessing Health Technology to Help Cancer Patients Quit Smoking PR Newswire ... using the ELEVATE program, increasing the likelihood of better outcomes.PLYMOUTH MEETING, Pa. New research in the May 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the inclusion of the smoking cessation tool Electronic Health Record-Enabled Evidence-Based Smoking Cessation Treatment (ELEVATE, from Epic) into electronic health records (EHRs) can increase self-reported patient quit rates by more than 5 percentage points. The study, from ...